Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ei Gains Exclusive World-Wide License for Sphingolipids - Happi
Company News

Ei Gains Exclusive World-Wide License for Sphingolipids

Advancements with 80% better moisture retention, said company.

Charlotte, NC-based Ei, A Pharmaceutical SolutionWorks, has signed agreements with European-based professors and technologists for the exclusive worldwide license of a novel class of sphingolipids. Sphingolipids are found in the extracellular spaces of the stratum corneum, where they play a critical role in strengthening the barrier function of the skin, promoting moisture retention and increasing elasticity of the skin, according to the company.

The specific technology consists of a novel lamellar lipid topically delivered through a custom formulation system. In preliminary clinical studies, the technology has demonstrated significantly better barrier function with substantial improvement in moisture retention when compared to commercially available sphingolipid compounds. As part of this exclusive licensing arrangement, Ei has been granted options on several related technologies in various stages of development.


Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters